Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20130926014779N5Phase 3Completed
Phase 3, randomised, triple-blind trial in nephrolithiasis comparing Bupivacaine intrathecal with Ropivacaine intrathecal (2 arms). Primary endpoints: Pain, Movement and 2 more. Started Dec 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20130926014779N5.